review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.4155/FMC.11.18 |
P698 | PubMed publication ID | 21554079 |
P2093 | author name string | Markus A Lill | |
Gregory L Wilson | |||
P2860 | cites work | Chemical Similarity Searching | Q28090770 |
P433 | issue | 6 | |
P304 | page(s) | 735-750 | |
P577 | publication date | 2011-04-01 | |
P1433 | published in | Future Medicinal Chemistry | Q19280078 |
P1476 | title | Integrating structure-based and ligand-based approaches for computational drug design | |
P478 | volume | 3 |
Q92589923 | A Structure-Based Drug Discovery Paradigm |
Q49226937 | A perspective on multi-target drug discovery and design for complex diseases. |
Q38750215 | Active learning for computational chemogenomics |
Q35206344 | Challenges, applications, and recent advances of protein-ligand docking in structure-based drug design. |
Q51709866 | Computational medicinal chemistry: part II. |
Q26997089 | Computational methods in drug discovery |
Q47319211 | Computational modeling in glioblastoma: from the prediction of blood-brain barrier permeability to the simulation of tumor behavior. |
Q36758674 | Design, synthesis, and biological evaluation of indenoisoquinoline rexinoids with chemopreventive potential |
Q91666838 | Discovery of monoamine oxidase inhibitors by medicinal chemistry approaches |
Q26745421 | Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies |
Q50940415 | Enhancing the Reliability of GPCR Models by Accounting for Flexibility of Their Pro-Containing Helices: the Case of the Human mAChR1 Receptor. |
Q35158672 | Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space |
Q26824875 | Global phenotypic screening for antimalarials |
Q36912176 | Identification of New Human Malaria Parasite Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors by Pharmacophore and Structure-Based Virtual Screening |
Q89597711 | In Silico Strategies in Tuberculosis Drug Discovery |
Q99545642 | In silico design and molecular docking study of CDK2 inhibitors with potent cytotoxic activity against HCT116 colorectal cancer cell line |
Q93126855 | Molecular Docking: Shifting Paradigms in Drug Discovery |
Q26800097 | Molecular docking and structure-based drug design strategies |
Q41478711 | Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach |
Q51527954 | Pharmacophore modeling, 3D-QSAR, and in silico ADME prediction of N-pyridyl and pyrimidine benzamides as potent antiepileptic agents. |
Q50252143 | Probing voltage sensing domain of KCNQ2 channel as a potential target to combat epilepsy: a comparative study. |
Q93202753 | Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein-ligand recognition process |
Q38252759 | Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors. |
Q38553677 | Role of computer-aided drug design in modern drug discovery. |
Q64273189 | Structural Perspective on Revealing and Altering Molecular Functions of Genetic Variants Linked with Diseases |
Q39003333 | Target-based molecular modeling strategies for schistosomiasis drug discovery. |
Q51603763 | Towards a Realistic Representation in Surface-Based Pseudoreceptor Modeling: a PDB-Wide Analysis of Binding Pockets. |
Q48184670 | Toxicodynamics of Mycotoxins in the Framework of Food Risk Assessment-An In Silico Perspective |
Q38933291 | Use of Integrated Computational Approaches in the Search for New Therapeutic Agents |
Search more.